Culturing human pluripotent stem cells for regenerative medicine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Culturing human pluripotent stem cells for regenerative medicine

Published:2023-06-03 Issue:6 Volume:23 Page:479-489
ISSN:1471-2598
Container-title:Expert Opinion on Biological Therapy
language:en
Short-container-title:Expert Opinion on Biological Therapy

Author:

Ozawa Hiroki¹^ORCID,Matsumoto Takuya²,Nakagawa Masato³

Affiliation:

1. Regenerative Medicine, Ajinomoto Health & Nutrition North America, Inc, Raleigh, NC, USA

2. Research Institute for Bioscience Products & Fine Chemicals, Ajinomoto Co Inc, Kawasaki, Japan

3. Department of Life Science Frontiers, Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan

Funder

Japan Agency for Medical Research and Development

iPS Cell Research Fund

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14712598.2023.2225701

Reference121 articles.

1. Embryonic Stem Cell Lines Derived from Human Blastocysts

2. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors

3. Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development

4. Pluripotent Stem Cell-Based Cell Therapy—Promise and Challenges

5. Enrichment of Neurons and Neural Precursors from Human Embryonic Stem Cells

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conditioned medium of induced pluripotent stem cell derived neuromesodermal progenitors enhances cell migration in vitro;Molecular Biology Reports;2024-03-23

2. Current Progress on the Curative Effects of Cell-Based Therapy for Patients with Non-Obstructive Azoospermia;Recent Advances in Male Reproductive System;2023-11-15

3. Xeno-free generation of new Yazd human embryonic stem cell lines (Yazd4-7) as a prior stage toward good manufacturing practice of clinical-grade raw materials from discarded embryos: A lab resources report;International Journal of Reproductive BioMedicine (IJRM);2023-09-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3